Hemoptysis in bronchiectasis and pulmonary infection
Conditions
Interventions
Phenolylamide treatment:None
Pituitrin therapy:None
Sponsors
Beijing Friendship Hospital Pinggu Campus,Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.All patients with confirmed bronchiectasis and pneumonia; 2.The patient is in normal mental state, without mental illness or speech dysfunction; 3.Age over 18,under 80 years of age;
Exclusion criteria
Exclusion criteria: 1.Exclusion of patients with drug allergy in this study; 2.Exclusion of patients with coagulation dysfunction and immune dysfunction; 3.Exclusion of lack of complete data; 4.Lactation and pregnancy exclusion;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether the symptoms of hemoptysis disappear within three days of medication; | — |
Secondary
| Measure | Time frame |
|---|---|
| Coagulation function;Adverse reactions; | — |
Countries
China
Contacts
Public ContactShanliangyu
Beijing Friendship Hospital Pinggu Campus,Capital Medical University
Outcome results
None listed